1 January 2012PatentsArchana Shanker

A step into the unknown: India's first compulsory license

The licence was granted to Natco Pharma, a generic drug company, for sorafenib tosylate, a life-extending drug developed, patented and launched by Bayer Corporation. This drug is sold under the trade name of Nexavar and is used for the treatment of advanced-stage kidney and liver cancer.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

India e-commerce: Liability for platforms is coming at last

24 September 2019 India’s booming e-commerce industry has remained largely immune to the cries of rights owners, but not for much longer, explains Pravin Anand, Jaya Negi and Souradeep Mukhopadhyay.

Influential Women in IP

The real impact of judgments

1 December 2020 Justice Prabha Sridevan has left her mark on the Indian IP industry, first as a judge of the Madras High Court, and then as chair of the Intellectual Property Appellate Board. Here, she tells WIPR about two cases that she will always remember.

UPC docs 'excessively redacted' under GDPR claims transparency lawyer

L'Oréal sued over virtual makeup try-on simulator

Kathi Vidal to leave USPTO ahead of incoming Trump administration

Q&A: EagleView counsel maps out route to IPR victory

WIPO in Saudi Arabia to finalise design law treaty

Douwe Egberts enjoys double shot over Nestlé in coffee patent rivalry

Startup CFO’s betrayal is a lesson in preparing for the worst

President Trump 2.0: Five major areas to watch

A step into the unknown: India's first compulsory license

More on this story

Editor's picks

Editor's picks

More articles